TIGIT blockade repolarizes AML-associated TIGIT⁺ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis

Abstract

Our findings suggest that immunosuppressive TIGIT⁺ M2 LAMs can be redirected into an efficient effector population that may be of direct clinical relevance in the near future.